Innovative treatment for children with high-risk neuroblastoma.
Wolfson Children’s Hospital provides MIBG treatment in partnership with Nemours Children's Health, Jacksonville and Baptist MD Anderson Cancer Center. Learn more
Physicians: to refer patients, email MIBG@nemours.org
Wolfson Children's is home to Florida’s first and only pediatric MIBG treatment center to treat high-risk neuroblastoma.
Metaiodobenzylguanidine (MIBG) therapy offers children with unresponsive or relapsed high-risk neuroblastoma a unique new therapy option.
Administered intravenously, this innovative radiation therapy specifically targets tumor cells and is not absorbed by any other cells in the body. The infusion lasts about 90 minutes, and is typically tolerated well.
Wolfson Children’s Hospital provides MIBG treatment in partnership with Nemours Children's Health, Jacksonville and Baptist MD Anderson Cancer Center. Learn more
Physicians: to refer patients, email MIBG@nemours.org
MIBG is administered in a specialized room with protective features to help manage patient and family safety. Parents have a separate, adjoining living space, along with a voice and video system, allowing families and patients to remain connected while reducing exposure to radiation.
Each patient is evaluated for MIBG on a case-by-case basis. Currently, we are considering patients who:
Time to Treatment
It takes about 6 weeks from receipt of physician referral to administration of MIBG therapy, as we require an in-person consultation and records, radiology images and pathology slides to review for every case.
Pediatric cancer specialists at Nemours Children’s Health, Jacksonville, work together with radiation oncologists at Baptist MD Anderson Cancer Center to provide this specialized MIBG treatment.
Co-Directors of MIBG Program:
Learn more about MIBG from the Nemours KidsHealth® website.
(en español)
Physicians at Wolfson Children's Hospital explain how MIBG treatment works.
Select a photo to open the full-sized gallery.
